Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
BIO
BIO
NYSE
Health Technology
Medical Specialties
305.96
USD
+4.26
+1.41%
마감됨: 07-22 20:00 (UTC+0)
305.96
USD
+1.34
+0.44%
장전: 07-23 08:26 (UTC+0)

BIO 주요 통계

고가
307.10
개시가
301.00
거래량
275.06K
저가
298.74
전일 종가
301.70
거래대금
84.03M
52주 최고가
343.12
상대 거래량
0.897
변동폭 (%)
2.77%
52주 최저가
236.73
회전율
1.27%
시가총액
8.18B
PER (TTM)
50.37
PER (연간)
10.978
PBR
1.2
PSR
3.16
주당순이익(EPS)
6.075
배당금(TTM)
0
배당수익률
0.00%
발행주식수
21.70M
통화 단위
USD

BIO 가격 수익률

7 일
30 일
90 일
180 일
연초 이후
1 년
BIO 자금 흐름 분포
BIO 일일 공매도 거래량
BIO 공매도 잔고 내역
As of 2026-07-23, the Bio-Rad Laboratories, Inc. (BIO) stock price today is 305.96. Based on this price, the company has a market capitalization of $8.18B, with a P/E ratio of 50.37. On 2026-07-23, BIO traded between 298.74 and 307.10. Today’s stock price is 2.42% above the daily low and 0.37% below the daily high, placing BIO 상단 부근에 its most recent trading range. Trading volume currently stands at 275.06K, compared with an average daily volume of 306.76K. This suggests that trading activity is 평소 수준과 대체로 비슷한 than usual. Over the past year, Bio-Rad Laboratories, Inc. shares have traded between 236.73 and 343.12. At today’s price, BIO is 29.24% above its 52-week low and 10.83% below its 52-week high.
회사 이름
Bio-Rad Laboratories, Inc.
섹터
Health Technology
산업
Medical Specialties
거래소
NYSE
직원 수
7,450
랏 크기
40
공식 웹사이트
통화 단위
USD
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

BIO FAQ

검색
더보기